Effects of mid-point imputation on the analysis of doubly censored data.
about
Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the artAre sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.Applying the Cox proportional hazards model for analysis of latency data with interval censoring.A proportional hazards model for multivariate interval-censored failure time data.Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.An overview of methods for interval-censored data with an emphasis on applications in dentistry.Analysis of colorectal adenoma recurrence data subject to informative censoring.Estimation of colorectal adenoma recurrence with dependent censoring.A Bayesian MCMC approach to survival analysis with doubly-censored data.Weighted logrank tests for interval censored data when assessment times depend on treatment.HIV prevalence and incidence in rural Tanzania: results from 10 years of follow-up in an open-cohort study.Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from Zimbabwe.Imputation methods for doubly censored HIV data.Methods for estimating the AIDS incubation time distribution when date of seroconversion is censored.Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.Estimation of recurrence of colorectal adenomas with dependent censoring using weighted logistic regression.Survival analysis in infectious disease research: describing events in timeT2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.Fibroblast growth factor 23 and incident CKD in type 2 diabetes.Meeting physical activity guidelines and the risk of incident knee osteoarthritis: a population-based prospective cohort study.Pleiotropic effects of obesity on fracture risk: the Study of Women's Health Across the NationHigh-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart StudyCombined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs.Rates and determinants of exclusive breastfeeding in first 6 months among women in Nova Scotia: a population-based cohort study.Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.A test for comparing current status survival data with crossing hazard functions and its application to immunogenicity of biotherapeutics.Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.Survival after HIV infection in the pre-antiretroviral therapy era in a rural Tanzanian cohort.Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study.Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.Incident HIV during pregnancy and early postpartum period: a population-based cohort study in a rural area in KwaZulu-Natal, South Africa.Surface-specific caries incidence in permanent molars in Danish children.Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.Heart rate variability and its relation to chronic kidney disease: Results from the PREVEND Study.Biopharmaceutical statistics beyond 2000.Interval-censored parametric regression survival models and the analysis of longitudinal trials.
P2860
Q26827335-A956AFD6-5C29-4F8D-9BDA-08F17331E55FQ30559409-61D8ABDE-F6E2-4E27-A434-E4ADC80110F8Q30582704-08CC133C-CC64-4C23-8635-FCDAEBC979BFQ30612541-9B6BA9BF-923A-42E4-A302-6FCA172D7558Q30857508-5C16F405-ED14-4240-BD39-3FA55387F78EQ31026279-2D968FC2-0F07-456E-84E2-7E270101060DQ33412059-28BE1BBD-839D-4615-8058-4705D9E742F0Q33507454-49B78EB4-2CA3-4148-846D-34C433F213B0Q33591387-E32A6773-5D91-4175-887B-6F9680070CB9Q33643602-1A0B23FF-4163-43D9-98EF-65E77ACF6D4AQ33743595-65145155-74C8-43AB-BB92-080D9A55A6D6Q33760375-E6572AB7-0639-4E30-A804-6DF1C28C1528Q33815357-024E91EB-EBC5-48C7-9B52-FFA276984A4CQ33937250-AADA938C-14C6-425B-A4D4-A110C0DCB18CQ34008233-5D267A54-D373-4AC7-93DB-88BCA583BDF5Q34069577-C4C50066-951B-4402-9F53-E8B4E2B586DAQ34195439-F170FEEC-0A68-401F-AE06-F698F714A030Q34410090-C7E5F205-6953-43AE-A4C7-2B9EDBDF529CQ34828731-F9AD5A35-F1A6-4DF5-9DCE-5796BA24DB3BQ35022807-D8FA43FD-64F2-4B88-B0D1-7D79FCEFBFEBQ35492429-5E505572-FD41-461C-91EE-6E0EBDCBFB75Q35973282-CDDD8C76-1532-4E6A-9836-9BCE6FBDC41FQ36270259-87CE22FD-9A2C-455E-8C03-7F3BBCF95510Q37394050-BAFE4350-7937-4352-8D9D-7B106418DF4AQ37701639-BB70844B-C07C-4A0E-90AE-E1E61A6ECFEFQ37978252-0D22F1B9-C2C8-4826-B5C9-7DA3A3695A16Q38600911-197E9092-E2D9-4DEE-BB40-5A425D633F1BQ38703134-D305727E-FC90-4C2B-B69C-6615BE86442DQ38780225-4DC01EBF-2C1F-4DFE-8BDB-A15ECC7F2178Q38877067-ABFAE904-A650-42BE-BAD8-96A03256F65BQ40660994-CEEA79A2-96D2-4E81-9B11-18F936421A59Q41139928-E4151D48-3746-41C9-96A8-E25FE0F28CE0Q41147372-B7AC71F8-29C7-4083-B82A-F4D1C5427545Q44376797-D49743D3-7A54-43EF-92F4-2274B3CEF29FQ44507445-8A29CDDE-75F3-446B-BC4F-8A2CB22C8AC7Q46075408-1F496586-A278-4181-B342-EB71ADCE8F6DQ48472661-40402585-D8C8-47AD-9277-D5FEE900C5AAQ49341879-61A13A17-029A-4E27-B112-058ECC5C2A3EQ52058927-51CEF270-A995-40EF-BD94-ACC1488D61ADQ53112187-A44F0A46-A072-481D-B53D-2D8C005CB629
P2860
Effects of mid-point imputation on the analysis of doubly censored data.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of mid-point imputation on the analysis of doubly censored data.
@ast
Effects of mid-point imputation on the analysis of doubly censored data.
@en
type
label
Effects of mid-point imputation on the analysis of doubly censored data.
@ast
Effects of mid-point imputation on the analysis of doubly censored data.
@en
prefLabel
Effects of mid-point imputation on the analysis of doubly censored data.
@ast
Effects of mid-point imputation on the analysis of doubly censored data.
@en
P356
P1476
Effects of mid-point imputation on the analysis of doubly censored data.
@en
P2093
P304
P356
10.1002/SIM.4780111204
P407
P577
1992-09-01T00:00:00Z